Physician profile
Kenneth T Sykes
NPI 1659568889
$1,357.55
in general payments reported to CMS, 2019-2025
8 companies · $874 in 2025
The $874 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $12.97 · 2021: $82.60 · 2022: $38.19 · 2023: $66.84 · 2024: $56.85 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $998.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $373.36 | 2023-2025 | Wavewriter Alpha Prime 16, Intracept |
| Stryker Corporation | $265.39 | 2025 | Mild Device Kit |
| Abbott Laboratories | $248.26 | 2019-2025 | Proclaim |
| Saluda Medical Americas, INC. | $242.11 | 2023-2025 | Evoke, Evoke Scs |
| Stimwave Technologies Incorporated | $159.79 | 2019-2021 | |
| Anika Therapeutics, INC. | $29.11 | 2024 | X-Twist |
| Smith+Nephew, INC. | $24.10 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $15.43 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Sykes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.